Literature DB >> 33961139

Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy.

Alessandro Zorzi1, Alberto Cipriani1, Riccardo Bariani1, Kalliopi Pilichou1, Domenico Corrado1, Barbara Bauce2.   

Abstract

PURPOSE OF REVIEW: The review addresses the role of exercise in triggering ventricular arrhythmias and promoting disease progression in arrhythmogenic cardiomyopathy (AC) patients and gene-mutation carriers, the differential diagnosis between AC and athlete's heart and current recommendations on exercise activity in AC. RECENT
FINDINGS: AC is an inherited heart muscle disease caused by genetically defective cell-to-cell adhesion structures (mainly desmosomes). The pathophysiological hallmark of the disease is progressive myocyte loss and replacement by fibro-fatty tissue, which creates the substrates for ventricular arrhythmias. Animal and human studies demonstrated that intense exercise, but not moderate physical activity, may increase disease penetrance, worsen the phenotype, and favor life-threatening ventricular arrhythmias. It has been proposed that in some individuals prolonged endurance sports activity may in itself cause AC (so-called exercise-induced AC). The studies agree that intense physical activity should be avoided in patients with AC and healthy gene-mutation carriers. However, low-to-moderate intensity exercise does not appear detrimental and these patients should not be entirely deprived from the many health benefits of physical activity.

Entities:  

Keywords:  Athlete’s heart; Exercise prescription; Sports cardiology; Sudden death; Ventricular arrhythmias

Mesh:

Year:  2021        PMID: 33961139      PMCID: PMC8105216          DOI: 10.1007/s11886-021-01489-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  54 in total

1.  Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2.

Authors:  Francisco M Cruz; David Sanz-Rosa; Marta Roche-Molina; Jaime García-Prieto; José M García-Ruiz; Gonzalo Pizarro; Luis J Jiménez-Borreguero; Miguel Torres; Antonio Bernad; Jesús Ruíz-Cabello; Valentín Fuster; Borja Ibáñez; Juan A Bernal
Journal:  J Am Coll Cardiol       Date:  2015-04-14       Impact factor: 24.094

Review 2.  Normative Reference Values of Right Heart in Competitive Athletes: A Systematic Review and Meta-Analysis.

Authors:  Flavio D'Ascenzi; Antonio Pelliccia; Marco Solari; Pietro Piu; Ferdinando Loiacono; Francesca Anselmi; Stefano Caselli; Marta Focardi; Marco Bonifazi; Sergio Mondillo
Journal:  J Am Soc Echocardiogr       Date:  2017-09       Impact factor: 5.251

3.  Safety of Sports for Young Patients With Implantable Cardioverter-Defibrillators: Long-Term Results of the Multinational ICD Sports Registry.

Authors:  Elizabeth Vickers Saarel; Ian Law; Charles I Berul; Michael J Ackerman; Ronald J Kanter; Shubhayan Sanatani; Mitchell I Cohen; Stuart Berger; Peter S Fischbach; David A Burton; James Dziura; Cynthia Brandt; Laura Simone; Fangyong Li; Brian Olshansky; David S Cannom; Rachel J Lampert
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-11

4.  Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance.

Authors:  Alberto Cipriani; Alessandro Zorzi; Patrizio Sarto; Martino Donini; Ilaria Rigato; Riccardo Bariani; Manuel De Lazzari; Kalliopi Pilichou; Gaetano Thiene; Sabino Iliceto; Cristina Basso; Domenico Corrado; Martina Perazzolo Marra; Barbara Bauce
Journal:  Heart Rhythm       Date:  2018-08-30       Impact factor: 6.343

5.  Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy.

Authors:  Frédéric L Paulin; Kathleen A Hodgkinson; Sarah MacLaughlan; Susan N Stuckless; Christina Templeton; Suryakant Shah; Heather Bremner; Jason D Roberts; Terry-Lynn Young; Patrick S Parfrey; Sean P Connors
Journal:  Heart Rhythm       Date:  2020-02-29       Impact factor: 6.343

6.  Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice.

Authors:  Larissa Fabritz; Mark G Hoogendijk; Brendon P Scicluna; Shirley C M van Amersfoorth; Lisa Fortmueller; Susanne Wolf; Sandra Laakmann; Nina Kreienkamp; Ilaria Piccini; Günter Breithardt; Patricia Ruiz Noppinger; Henning Witt; Klaus Ebnet; Thomas Wichter; Bodo Levkau; Werner W Franke; Sebastian Pieperhoff; Jacques M T de Bakker; Ruben Coronel; Paulus Kirchhof
Journal:  J Am Coll Cardiol       Date:  2011-02-08       Impact factor: 24.094

7.  Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mark J Perrin; Paul Angaran; Zachary Laksman; Hanfei Zhang; Liane F Porepa; Julie Rutberg; Cynthia James; Andrew D Krahn; Daniel P Judge; Hugh Calkins; Michael H Gollob
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094

Review 8.  The prevalence and clinical significance of premature ventricular beats in the athlete.

Authors:  F D'Ascenzi; A Zorzi; F Alvino; M Bonifazi; D Corrado; S Mondillo
Journal:  Scand J Med Sci Sports       Date:  2016-03-31       Impact factor: 4.221

9.  Burden of ventricular arrhythmias at 12-lead 24-hour ambulatory ECG monitoring in middle-aged endurance athletes versus sedentary controls.

Authors:  Alessandro Zorzi; Giulio Mastella; Alberto Cipriani; Giampaolo Berton; Alvise Del Monte; Beatrice Gusella; Alberto Nese; Leonardo Portolan; Federico Sciacca; Suada Tikvina; Saverio Tollot; Domenico Trovato; Sabino Iliceto; Maurizio Schiavon; Domenico Corrado
Journal:  Eur J Prev Cardiol       Date:  2018-08-30       Impact factor: 7.804

10.  Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members.

Authors:  Jørg Saberniak; Nina E Hasselberg; Rasmus Borgquist; Pyotr G Platonov; Sebastian I Sarvari; Hans-Jørgen Smith; Margareth Ribe; Anders G Holst; Thor Edvardsen; Kristina H Haugaa
Journal:  Eur J Heart Fail       Date:  2014-10-16       Impact factor: 15.534

View more
  6 in total

1.  GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy.

Authors:  Chiara Volani; Alessandra Pagliaro; Johannes Rainer; Giuseppe Paglia; Benedetta Porro; Ilaria Stadiotti; Luisa Foco; Elisa Cogliati; Adolfo Paolin; Costanza Lagrasta; Caterina Frati; Emilia Corradini; Angela Falco; Theresa Matzinger; Anne Picard; Benedetta Ermon; Silvano Piazza; Marzia De Bortoli; Claudio Tondo; Réginald Philippe; Andrea Medici; Alexandros A Lavdas; Michael J F Blumer; Giulio Pompilio; Elena Sommariva; Peter P Pramstaller; Jakob Troppmair; Viviana Meraviglia; Alessandra Rossini
Journal:  J Cell Mol Med       Date:  2022-06-16       Impact factor: 5.295

2.  New Variant in Placophilin-2 Gene Causing Arrhythmogenic Myocardiopathy.

Authors:  Fiama Caimi-Martinez; Guido Antoniutti; Rocio Blanco; Bernardo García de la Villa; Nelson Alvarenga; Nancy Govea-Callizo; Laura Torres-Juan; Damián Heine-Suñer; Jordi Rosell-Andreo; David Crémer Luengos; Jorge Alvarez-Rubio; Tomás Ripoll-Vera
Journal:  Genes (Basel)       Date:  2022-04-27       Impact factor: 4.141

Review 3.  Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?

Authors:  Viviana Meraviglia; Mireia Alcalde; Oscar Campuzano; Milena Bellin
Journal:  Front Cardiovasc Med       Date:  2021-12-20

4.  Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity.

Authors:  Anneline S J M Te Riele; Cynthia A James; Hugh Calkins; Adalena Tsatsopoulou
Journal:  Front Pediatr       Date:  2021-12-02       Impact factor: 3.418

Review 5.  Cardiopulmonary Resuscitation and Defibrillator Use in Sports.

Authors:  Mafalda Carrington; Rui Providência; C Anwar A Chahal; Flavio D'Ascenzi; Alberto Cipriani; Fabrizio Ricci; Mohammed Y Khanji
Journal:  Front Cardiovasc Med       Date:  2022-02-15

Review 6.  Arrhythmogenic Cardiomyopathy: Exercise Pitfalls, Role of Connexin-43, and Moving beyond Antiarrhythmics.

Authors:  Isabella Leite Coscarella; Maicon Landim-Vieira; José Renato Pinto; Stephen P Chelko
Journal:  Int J Mol Sci       Date:  2022-08-06       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.